Tamiflu, an antiviral medication, is not inherently "bad" but rather has limitations and potential side effects that are important for patients and healthcare providers to understand. Its effectiveness and safety profile are subject to ongoing evaluation.
What is Tamiflu prescribed for?
Tamiflu (oseltamivir) is primarily prescribed to treat influenza (the flu) in people aged one year and older who have had flu symptoms for no more than 48 hours [1]. It can also be used to prevent the flu in individuals one year and older who may be exposed to the influenza virus [1]. Tamiflu works by inhibiting neuraminidase, an enzyme that helps the influenza virus spread within the body [2].
What are the common side effects of Tamiflu?
Common side effects associated with Tamiflu include nausea, vomiting, and headache [1]. While these are generally mild, they can be distressing for some individuals.
Are there serious side effects linked to Tamiflu?
In rare instances, more serious side effects have been reported. These can include neuropsychiatric events, such as confusion, delirium, hallucinations, self-injury, and even death, particularly in children and adolescents [1]. However, a direct causal link between Tamiflu and these events has not been definitively established, and such events have also been observed in individuals with influenza who were not taking the medication [3]. Allergic reactions, including skin rashes and severe breathing difficulties, are also possible [1].
How effective is Tamiflu in treating the flu?
Tamiflu can reduce the duration of flu symptoms by about one day. It is most effective when started within 48 hours of symptom onset [1]. While Tamiflu can decrease the risk of flu-related complications, such as pneumonia, it does not eliminate the risk [1].
When does Tamiflu patent exclusivity expire?
Information on Tamiflu's patent exclusivity and potential generic availability can be found on DrugPatentWatch.com [4]. Patent expiration dates are crucial for understanding when generic versions of a drug may enter the market, potentially impacting pricing and accessibility.
What are the alternatives to Tamiflu for flu treatment?
Other neuraminidase inhibitors, such as zanamivir (Relenza) and peramivir (Rapivab), are also available for treating influenza [5]. These medications have similar mechanisms of action and potential side effects. Baloxavir marboxil (Xofluza) is another antiviral option that works differently by targeting a different viral protein [5].
Who makes Tamiflu?
Tamiflu is manufactured by Genentech, a member of the Roche Group [6].
---
Sources:
1. https://www.drugs.com/tamiflu.html
2. https://www.rxlist.com/tamiflu-drug.htm
3. https://www.fda.gov/vaccines-blood-biologics/qa-influenza/influenza-antiviral-medications-and-influenza-prevention-what-you-should-know
4. https://drugpatentwatch.com/
5. https://www.cdc.gov/flu/treatment/what-to-do-if-you-get-sick.htm
6. https://www.gene.com/medicines/respiratory/tamiflu